Cargando…
A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice
Histone deacetylase (HDAC) inhibitors, which regulate gene expression by inhibiting the deacetylation of histones and nonhistone proteins, have been shown to exert a wide array of biological effects; these include anti-cancer, anti-obesity, and anti-diabetes effects, as well as cardiovascular-protec...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758468/ https://www.ncbi.nlm.nih.gov/pubmed/33362555 http://dx.doi.org/10.3389/fphar.2020.601448 |
_version_ | 1783626946770370560 |
---|---|
author | Lee, Soo Jin Choi, Sung-E Lee, Han Byeol Song, Min-Woo Kim, Young Ha Jeong, Jae Yeop Kang, Yup Kim, Hae Jin Kim, Tae Ho Jeon, Ja Young Lee, Kwan Woo |
author_facet | Lee, Soo Jin Choi, Sung-E Lee, Han Byeol Song, Min-Woo Kim, Young Ha Jeong, Jae Yeop Kang, Yup Kim, Hae Jin Kim, Tae Ho Jeon, Ja Young Lee, Kwan Woo |
author_sort | Lee, Soo Jin |
collection | PubMed |
description | Histone deacetylase (HDAC) inhibitors, which regulate gene expression by inhibiting the deacetylation of histones and nonhistone proteins, have been shown to exert a wide array of biological effects; these include anti-cancer, anti-obesity, and anti-diabetes effects, as well as cardiovascular-protective activity. However, the effects of class I HDAC inhibition on lipotoxicity in C2C12 myotubes and skeletal muscle tissue remain poorly understood. In this study, we investigated the molecular mechanism underlying the protective effect of class I HDAC inhibition under lipotoxic conditions, i.e., in palmitate (PA)-treated C2C12 myotubes and skeletal muscle tissue in high fat (HF)/high fructose (HFr) diet mice. PA treatment of C2C12 myotubes increased HDAC3 protein expression and impaired mitochondrial oxidation, resulting in increased mitochondrial ROS generation and an accumulation of intracellular triglycerides (TG). Prolonged exposure led to increased inflammatory cytokine expression and insulin resistance. In contrast, MS-275, a class I HDAC inhibitor, dramatically attenuated lipotoxicity, preventing PA-induced insulin resistance and inflammatory cytokine expression. Similar beneficial effects were also seen following HDAC3 knockdown. In addition, MS-275 increased the mRNA expression of peroxisome proliferator activator receptor γ-coactivator 1α (PGC1α) and mitochondrial transcription factor A (TFAM), which serve as transcriptional coactivators in the context of mitochondrial metabolism and biogenesis, and restored expression of peroxisome proliferator-activated receptor alpha (PPARα), medium-chain acyl-coenzyme A dehydrogenase (MCAD), enoyl-CoA hydratase, and 3-hydroxyacyl CoA dehydrogenase (EHHADH). In vivo, treatment of HF/HFr-fed mice with MS-275 ameliorated hyperglycemia, insulin resistance, stress signals, and TNF-α expression in skeletal muscle. Taken together, these results suggest that HDAC3 inhibition rather than HDAC1/2 inhibition by MS-275 protects against lipotoxicity in C2C12 myotubes and skeletal muscle, and may be effective for the treatment of obesity and insulin resistance. |
format | Online Article Text |
id | pubmed-7758468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77584682020-12-25 A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice Lee, Soo Jin Choi, Sung-E Lee, Han Byeol Song, Min-Woo Kim, Young Ha Jeong, Jae Yeop Kang, Yup Kim, Hae Jin Kim, Tae Ho Jeon, Ja Young Lee, Kwan Woo Front Pharmacol Pharmacology Histone deacetylase (HDAC) inhibitors, which regulate gene expression by inhibiting the deacetylation of histones and nonhistone proteins, have been shown to exert a wide array of biological effects; these include anti-cancer, anti-obesity, and anti-diabetes effects, as well as cardiovascular-protective activity. However, the effects of class I HDAC inhibition on lipotoxicity in C2C12 myotubes and skeletal muscle tissue remain poorly understood. In this study, we investigated the molecular mechanism underlying the protective effect of class I HDAC inhibition under lipotoxic conditions, i.e., in palmitate (PA)-treated C2C12 myotubes and skeletal muscle tissue in high fat (HF)/high fructose (HFr) diet mice. PA treatment of C2C12 myotubes increased HDAC3 protein expression and impaired mitochondrial oxidation, resulting in increased mitochondrial ROS generation and an accumulation of intracellular triglycerides (TG). Prolonged exposure led to increased inflammatory cytokine expression and insulin resistance. In contrast, MS-275, a class I HDAC inhibitor, dramatically attenuated lipotoxicity, preventing PA-induced insulin resistance and inflammatory cytokine expression. Similar beneficial effects were also seen following HDAC3 knockdown. In addition, MS-275 increased the mRNA expression of peroxisome proliferator activator receptor γ-coactivator 1α (PGC1α) and mitochondrial transcription factor A (TFAM), which serve as transcriptional coactivators in the context of mitochondrial metabolism and biogenesis, and restored expression of peroxisome proliferator-activated receptor alpha (PPARα), medium-chain acyl-coenzyme A dehydrogenase (MCAD), enoyl-CoA hydratase, and 3-hydroxyacyl CoA dehydrogenase (EHHADH). In vivo, treatment of HF/HFr-fed mice with MS-275 ameliorated hyperglycemia, insulin resistance, stress signals, and TNF-α expression in skeletal muscle. Taken together, these results suggest that HDAC3 inhibition rather than HDAC1/2 inhibition by MS-275 protects against lipotoxicity in C2C12 myotubes and skeletal muscle, and may be effective for the treatment of obesity and insulin resistance. Frontiers Media S.A. 2020-12-10 /pmc/articles/PMC7758468/ /pubmed/33362555 http://dx.doi.org/10.3389/fphar.2020.601448 Text en Copyright © 2020 Lee, Choi, Lee, Song, Kim, Jeong, Kang, Kim, Kim, Jeon and Lee http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Lee, Soo Jin Choi, Sung-E Lee, Han Byeol Song, Min-Woo Kim, Young Ha Jeong, Jae Yeop Kang, Yup Kim, Hae Jin Kim, Tae Ho Jeon, Ja Young Lee, Kwan Woo A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice |
title | A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice |
title_full | A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice |
title_fullStr | A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice |
title_full_unstemmed | A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice |
title_short | A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice |
title_sort | class i histone deacetylase inhibitor attenuates insulin resistance and inflammation in palmitate-treated c2c12 myotubes and muscle of hf/hfr diet mice |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758468/ https://www.ncbi.nlm.nih.gov/pubmed/33362555 http://dx.doi.org/10.3389/fphar.2020.601448 |
work_keys_str_mv | AT leesoojin aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT choisunge aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT leehanbyeol aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT songminwoo aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT kimyoungha aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT jeongjaeyeop aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT kangyup aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT kimhaejin aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT kimtaeho aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT jeonjayoung aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT leekwanwoo aclassihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT leesoojin classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT choisunge classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT leehanbyeol classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT songminwoo classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT kimyoungha classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT jeongjaeyeop classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT kangyup classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT kimhaejin classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT kimtaeho classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT jeonjayoung classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice AT leekwanwoo classihistonedeacetylaseinhibitorattenuatesinsulinresistanceandinflammationinpalmitatetreatedc2c12myotubesandmuscleofhfhfrdietmice |